RecruitingNot Applicable

Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

United States37,122 participantsStarted 2024-07-23

Plain-language summary

The goal of this study is to reduce morbidity and mortality from COVID-19 amongst people who are detained in and work in correctional facilities. The overall objective is to identify feasible and effective interventions to improve vaccine uptake in correctional facilities and study the effectiveness of these interventions through rapid cycle, cluster randomized trials in the Pennsylvania prison system.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * All incarcerated people in the Pennsylvania DOC are included in the study population for these low risk interventions. In this each individual intervention, inclusion criteria will be based on where incarcerated people are housed and therefore what intervention they will be exposed to. Exclusion Criteria: * Exclusion criteria will likely include severe physical or mental illness as these individuals are often incarcerated in special units which will not be included in the study (i.e. medical units).

What they're measuring

COVID-19 vaccine acceptance rate

Timeframe: up to 12 weeks post intervention

Trial details

NCT IDNCT05796505

SponsorYale University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Lisa B Puglisi, MD

475-306-1023 Lisa.puglisi@yale.edu

View on ClinicalTrials.gov More COVID-19 trials